Dopamine Agonists and their risk to induce psychotic episodes in Parkinson's disease: a case-control study

被引:0
作者
Daniel Ecker
Alexander Unrath
Jan Kassubek
Michael Sabolek
机构
[1] University of Ulm,Department of Neurology
[2] EMA-University of Greifswald,Department of Neurology
[3] Focus Clinical Drug Development,undefined
来源
BMC Neurology | / 9卷
关键词
Levodopa; Psychotic Symptom; Dopamine Agonist; Dementia With Lewy Body; White Matter Lesion;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 210 条
  • [1] Weintraub D(2006)Frequency and correlates of co-morbid psychosis and depression in Parkinson's disease Parkinsonism & related disorders 12 427-431
  • [2] Morales KH(2005)Psychiatric complications in Parkinson disease Am J Geriatr Psychiatry 13 844-851
  • [3] Duda JE(1996)The occurrence of depression in Parkinson's disease. A community-based study Arch Neurol 53 175-179
  • [4] Moberg PJ(1984)Parkinson's disease in 1984: an update Canadian Medical Association journal 131 1031-1037
  • [5] Stern MB(1991)Behavioral complications of drug treatment of Parkinson's disease J Am Geriatr Soc 39 708-716
  • [6] Weintraub D(1989)Psychiatric aspects of Parkinson's disease BMJ (Clinical research ed) 299 3-4
  • [7] Stern MB(1996)Visual hallucinations in a geriatric psychiatry clinic: prevalence and associated diagnoses Journal of geriatric psychiatry and neurology 9 171-175
  • [8] Tandberg E(2001)Visual hallucinations in Parkinson's disease: a review and phenomenological survey Journal of neurology, neurosurgery, and psychiatry 70 727-733
  • [9] Larsen JP(1995)Parkinson's disease: drug-induced psychiatric states Advances in neurology 65 115-138
  • [10] Aarsland D(2000)Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors Brain 123 733-745